To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines
Clinical trial NCT00140686 · COMPLETED
Trial details
- NCT number
- NCT00140686
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-09-01
- Primary completion
- 2006-08-01
- Enrollment
- 3994
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.